These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 29627320)

  • 1. TRIM24 promotes hepatocellular carcinoma progression via AMPK signaling.
    Zhu Y; Zhao L; Shi K; Huang Z; Chen B
    Exp Cell Res; 2018 Jun; 367(2):274-281. PubMed ID: 29627320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of NAD(P)H: Quinone Oxidoreductase 1 Inhibits Hepatocellular Carcinoma Cell Proliferation and Induced Apoptosis by Activating AMPK/PGC-1α Pathway.
    Zhang X; Han K; Yuan DH; Meng CY
    DNA Cell Biol; 2017 Apr; 36(4):256-263. PubMed ID: 28191864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of AMPK activation and therapeutic effects of metformin in hepatocellular carcinoma.
    Zheng L; Yang W; Wu F; Wang C; Yu L; Tang L; Qiu B; Li Y; Guo L; Wu M; Feng G; Zou D; Wang H
    Clin Cancer Res; 2013 Oct; 19(19):5372-80. PubMed ID: 23942093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Palbociclib induces activation of AMPK and inhibits hepatocellular carcinoma in a CDK4/6-independent manner.
    Hsieh FS; Chen YL; Hung MH; Chu PY; Tsai MH; Chen LJ; Hsiao YJ; Shih CT; Chang MJ; Chao TI; Shiau CW; Chen KF
    Mol Oncol; 2017 Aug; 11(8):1035-1049. PubMed ID: 28453226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SKP2 Promotes Hepatocellular Carcinoma Progression Through Nuclear AMPK-SKP2-CARM1 Signaling Transcriptionally Regulating Nutrient-Deprived Autophagy Induction.
    Wei X; Li X; Yan W; Zhang X; Sun Y; Zhang F
    Cell Physiol Biochem; 2018; 47(6):2484-2497. PubMed ID: 29991055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCL17 promotes cell metastasis and inhibits autophagy via the LKB1-AMPK pathway in hepatocellular carcinoma.
    Wang L; Li H; Zhen Z; Ma X; Yu W; Zeng H; Li L
    Gene; 2019 Mar; 690():129-136. PubMed ID: 30597237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sauchinone exerts anticancer effects by targeting AMPK signaling in hepatocellular carcinoma cells.
    Kim YW; Jang EJ; Kim CH; Lee JH
    Chem Biol Interact; 2017 Jan; 261():108-117. PubMed ID: 27871897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bifunctional enzyme ATIC promotes propagation of hepatocellular carcinoma by regulating AMPK-mTOR-S6 K1 signaling.
    Li M; Jin C; Xu M; Zhou L; Li D; Yin Y
    Cell Commun Signal; 2017 Dec; 15(1):52. PubMed ID: 29246230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naa20, the catalytic subunit of NatB complex, contributes to hepatocellular carcinoma by regulating the LKB1-AMPK-mTOR axis.
    Jung TY; Ryu JE; Jang MM; Lee SY; Jin GR; Kim CW; Lee CY; Kim H; Kim E; Park S; Lee S; Lee C; Kim W; Kim T; Lee SY; Ju BG; Kim HS
    Exp Mol Med; 2020 Nov; 52(11):1831-1844. PubMed ID: 33219302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SCD1 negatively regulates autophagy-induced cell death in human hepatocellular carcinoma through inactivation of the AMPK signaling pathway.
    Huang GM; Jiang QH; Cai C; Qu M; Shen W
    Cancer Lett; 2015 Mar; 358(2):180-190. PubMed ID: 25528629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simvastatin-induced cell cycle arrest through inhibition of STAT3/SKP2 axis and activation of AMPK to promote p27 and p21 accumulation in hepatocellular carcinoma cells.
    Wang ST; Ho HJ; Lin JT; Shieh JJ; Wu CY
    Cell Death Dis; 2017 Feb; 8(2):e2626. PubMed ID: 28230855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AMP-activated protein kinase suppresses the in vitro and in vivo proliferation of hepatocellular carcinoma.
    Cheng J; Huang T; Li Y; Guo Y; Zhu Y; Wang Q; Tan X; Chen W; Zhang Y; Cheng W; Yamamoto T; Jing X; Huang J
    PLoS One; 2014; 9(4):e93256. PubMed ID: 24709998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycochenodeoxycholate promotes hepatocellular carcinoma invasion and migration by AMPK/mTOR dependent autophagy activation.
    Gao L; Lv G; Li R; Liu WT; Zong C; Ye F; Li XY; Yang X; Jiang JH; Hou XJ; Jing YY; Han ZP; Wei LX
    Cancer Lett; 2019 Jul; 454():215-223. PubMed ID: 30980867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 6PGD inhibition sensitizes hepatocellular carcinoma to chemotherapy via AMPK activation and metabolic reprogramming.
    Chen H; Wu D; Bao L; Yin T; Lei D; Yu J; Tong X
    Biomed Pharmacother; 2019 Mar; 111():1353-1358. PubMed ID: 30841449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein phosphatase 5 promotes hepatocarcinogenesis through interaction with AMP-activated protein kinase.
    Chen YL; Hung MH; Chu PY; Chao TI; Tsai MH; Chen LJ; Hsiao YJ; Shih CT; Hsieh FS; Chen KF
    Biochem Pharmacol; 2017 Aug; 138():49-60. PubMed ID: 28528695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zic2 promotes tumor growth and metastasis via PAK4 in hepatocellular carcinoma.
    Lu SX; Zhang CZ; Luo RZ; Wang CH; Liu LL; Fu J; Zhang L; Wang H; Xie D; Yun JP
    Cancer Lett; 2017 Aug; 402():71-80. PubMed ID: 28577975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The activation of MEK/ERK signaling pathway by bone morphogenetic protein 4 to increase hepatocellular carcinoma cell proliferation and migration.
    Chiu CY; Kuo KK; Kuo TL; Lee KT; Cheng KH
    Mol Cancer Res; 2012 Mar; 10(3):415-27. PubMed ID: 22241220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HOXB7 promotes tumor progression via bFGF-induced activation of MAPK/ERK pathway and indicated poor prognosis in hepatocellular carcinoma.
    Wang WM; Xu Y; Wang YH; Sun HX; Sun YF; He YF; Zhu QF; Hu B; Zhang X; Xia JL; Qiu SJ; Zhou J; Yang XR; Fan J
    Oncotarget; 2017 Jul; 8(29):47121-47135. PubMed ID: 28454092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose metformin suppresses hepatocellular carcinoma metastasis via the AMPK/JNK/IL-8 pathway.
    Zhao C; Zheng L; Ma Y; Zhang Y; Yue C; Gu F; Niu G; Chen Y
    Int J Immunopathol Pharmacol; 2024; 38():3946320241249445. PubMed ID: 38679570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin and glucose starvation decrease the migratory ability of hepatocellular carcinoma cells: targeting AMPK activation to control migration.
    Ferretti AC; Hidalgo F; Tonucci FM; Almada E; Pariani A; Larocca MC; Favre C
    Sci Rep; 2019 Feb; 9(1):2815. PubMed ID: 30809021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.